Skip to main content

Table 1 Clinical features of 80 breast cancer patients

From: Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencing

Characteristic

n (%)

Age (years)

Median: 56

 

Range: 30–75

HR status

HR+

65 (81.3%)

HR−

15 (18.8%)

HER2 status

HER2+

12 (15.0%)

HER2++

18 (22.5%)

HER2+++

1 (1.3%)

HER2−

44 (55.0%)

Unknown

5 (6.3%)

AJCC/TNM stage

2a

19 (23.8%)

2b

26 (32.5%)

3a

23 (28.8%)

3b

4 (8.8%)

3c

7 (8.8%)

4

1 (1.3%)

Pathological diagnosis of infiltrating ductal carcinoma

IDC2

71 (88.8%)

IDC3

6 (7.5%)

Others

3 (3.8%)